Keyphrases
Activating mutation
33%
BRAF mutation
33%
Carcinoma Cells
33%
Cell Migration
33%
Drug-resistant Cancer
33%
ERK Activity
66%
ERK Inhibition
33%
ERK Pathway
33%
Extracellular Regulated Protein Kinases
33%
Functional Loops
33%
Future Therapies
33%
IL-8 Production
33%
In Vivo Growth
33%
Integrin
66%
Melanoma
100%
Melanoma Cells
33%
Metastatic Site
33%
Mitogen-activated Protein Kinase
33%
Mutually Exclusive
33%
Negative Feedback
33%
NRAS mutation
33%
P38 Signaling Pathway
33%
Pathway Activation
33%
Positive Functional
33%
Stress-activated Protein Kinase
33%
Surface Expression
33%
Tumorigenesis
33%
Vitronectin
33%
Medicine and Dentistry
Cancer
33%
Carcinogenesis
33%
Carcinoma Cell
33%
Cell Migration
33%
Cell Signaling Pathway
33%
Integrin
66%
Kinase
66%
Melanoma
100%
Melanoma Cell Line
33%
Mitogen-Activated Protein Kinase
33%
Negative Feedback
33%
Phosphotransferase
33%
Protein Kinases
33%
Stress Activated Protein Kinase
33%
Vitronectin
33%
Biochemistry, Genetics and Molecular Biology
C-Jun N-Terminal Kinases
50%
Carcinogenesis
50%
Cell Migration
50%
Integrin
100%
Interleukin 8
50%
Kinase
50%
Mitogen-Activated Protein Kinase
50%
Phosphotransferase
50%
Product Inhibition
50%
Protein Kinases
50%
Vitronectin
50%
Neuroscience
C-Jun N-Terminal Kinases
33%
Carcinogenesis
33%
Cell Line
33%
Cell Migration
33%
Cell Signaling
33%
In Vivo
100%
Integrin
66%
Interleukin 8
33%
Kinase
33%
Mitogen-Activated Protein Kinase
33%
Negative Feedback
33%
Protein Kinases
33%
Vitronectin
33%
Immunology and Microbiology
Carcinoma Cell
50%
Cell Migration
50%
Integrin
100%
Interleukin 8
50%
Melanoma Cell Line
50%
Mitogen
50%
Negative Feedback
50%
Pharmacology, Toxicology and Pharmaceutical Science
Carcinogenesis
25%
Carcinoma
25%
Integrin
50%
Melanoma
100%
Mitogen Activated Protein Kinase
25%
Phosphotransferase
25%
Protein Kinases
25%
Stress Activated Protein Kinase
25%
Vitronectin
25%